In our previous instalment, we revealed an international syndicate running online trading ‘scams’ worldwide that had a prominent presence in South Africa. Now we turn to the ‘back office’ running the ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture ...

Explore Eve Holding's Q4 2024 earnings call highlights, featuring eVTOL milestones, $429M liquidity, $14B pre-order backlog, and 2027 certification goals.

Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...

AISERA—A leading provider of generative AI solu- tions, Aisera helps enterprises boost revenue, improve user productivity, lower operating expenses, and create magical user experiences ... business ...

A bill that would generate new revenue for the state to address climate change and reduce the risk of future wildfires by ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...

Conference Call and Webcast Today at 8:30 a.m. ETReached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical ...

the company implemented a series of measures in connection with moving to an outsourced analytical testing model and to reduce operating expenses. As a result, the company's cash runway was extended ...

Mogotes has systematically consolidated an approximately 10,000 Ha claims package at the Company's Filo Sur project that ...